Skip to main content
. 2022 Sep 30;71(39):1241–1246. doi: 10.15585/mmwr.mm7139e1

FIGURE.

The two-paneled figure shows the percentage of annual transcranial Doppler ultrasound screening (A) and hydroxyurea use (B) among children and adolescents aged 2–16 years with sickle cell anemia, in selected U.S. states, in 2014 and 2019.

Percentage of annual transcranial Doppler ultrasound screening (A) and hydroxyurea use (B) among children and adolescents aged 2–16 years with sickle cell anemia* — selected U.S. states, 2014 and 2019

Abbreviation: TCD = transcranial Doppler.

* With 95% CIs indicated by error bars.